## Featured Research

from universities, journals, and other organizations

# Using maths, researchers seek to improve success in transplants

Date:
December 24, 2013
Source:
Investigación y Desarrollo
Summary:
Given that 10.5 % of patients who receive a transplant reject the new organ, researchers are working in the design of a tool capable of preventing this problem. The process consists in knowing the type of proteins in charge of metabolizing the drugs (enzymes) for each patient which would, helped by a mathematical model, allow to establish the exact dose needed of the immunosuppressive drugs required.

Given that 10.5 % of patients who receive a transplant reject the new organ, researchers at the Center of Research and Advanced Studies of the National Polytechnic Institute (Cinvestav) are working in the design of a tool capable of preventing this problem. The process consists in knowing the type of proteins in charge of metabolizing the drugs (enzymes) for each patient which would, helped by a mathematical model, allow to establish the exact dose needed of the immunosuppressive drugs required.

This method will be capable of giving an effective certainty at the moment of establishing the treatment, will also save time and decrease rejection, increasing the quality of life, allowing the survival of more patients and optimizing the health system, informed Gilberto Castañeda Hernández from the department of Pharmacology.

According to the researcher, the enzymes that process the drugs have various grades of activity, so the immunosuppressive can be eliminated slowly or rapidly. Hence, the necessity of knowing, using genetic studies, what kind of proteins each person has to determine the adequate portion of the drug.

Every study is being carried in order to create a mathematical algorithm that will indicate for each person, using their genetics, size, age, current medication and time since the transplant, what should their immunosuppressive drug dosage should be.

Currently, the quantity of drug to be administrated is determined by trial and error; however, this process takes long and gives place to complications that are translated to an acute rejection.

"For example, the dosage that is used in Germany of the drug Nifedipine is not adequate for Mexicans because it gives them headaches, tachycardia and vasodilation, among other problems," says Castañeda Hernández.

The challenge will be to identify the patients that quickly metabolize the immunosuppressive such as Tacrolimus and Ciclosporin. "In Mexico both exist and its dosage is not the same as used in Europe or the United States; we have to find our own genetic variations."

In Mexico, a window of opportunity is to apply this system to kids, making it possible to determine the immunosuppressive treatment correctly. The child population has a special metabolism because of its development; hence, applying the analysis tools would have better results, assured Castañeda Hernández.

Story Source:

The above story is based on materials provided by Investigación y Desarrollo. Note: Materials may be edited for content and length.

Investigación y Desarrollo. "Using maths, researchers seek to improve success in transplants." ScienceDaily. ScienceDaily, 24 December 2013. <www.sciencedaily.com/releases/2013/12/131224183545.htm>.
Investigación y Desarrollo. (2013, December 24). Using maths, researchers seek to improve success in transplants. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2013/12/131224183545.htm
Investigación y Desarrollo. "Using maths, researchers seek to improve success in transplants." ScienceDaily. www.sciencedaily.com/releases/2013/12/131224183545.htm (accessed July 24, 2014).

## More Health & Medicine News

Thursday, July 24, 2014

### Featured Research

from universities, journals, and other organizations

### Featured Videos

from AP, Reuters, AFP, and other news services

Condemned Man's US Execution Takes Nearly Two Hours

### Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) — America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
China's Ageing Millions Look Forward to Bleak Future

### China's Ageing Millions Look Forward to Bleak Future

AFP (July 24, 2014) — China's elderly population is expanding so quickly that children struggle to look after them, pushing them to do something unexpected in Chinese society- move their parents into a nursing home. Duration: 02:07 Video provided by AFP
Hundreds in Virginia Turn out for a Free Clinic to Manage Health

### Hundreds in Virginia Turn out for a Free Clinic to Manage Health

AFP (July 24, 2014) — America may be the world’s richest country, but in terms of healthcare, the World Health Organisation ranks it 37th - prompting hundreds in Virginia to turn out for a free clinic run by “Remote Area Medical”. Duration 02:40 Video provided by AFP
Idaho Boy Helps Brother With Disabilities Complete Triathlon

### Idaho Boy Helps Brother With Disabilities Complete Triathlon

Newsy (July 23, 2014) — An 8-year-old boy helped his younger brother, who has a rare genetic condition that's confined him to a wheelchair, finish a triathlon. Video provided by Newsy

## Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):

Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

## In Other News

... from NewsDaily.com

Save/Print:
Share:

## Free Subscriptions

Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

## Get Social & Mobile

Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

## Have Feedback?

Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web